Active HHV-6 infection in the lymph nodes of HIV-infected patients: In vitro evidence that HHV-6 can break HIV latency

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 11, Issue 4, 1996, Pages 370-378

  Knox, Konstance Kehl ^a,b   Carrigan, Donald R ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b ST LUKE S MEDICAL CENTER   (United States)

Author keywords

HHV 6; Latency HIV; Lymph node

Indexed keywords

CD4 ANTIGEN;

ARTICLE; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LATENT PERIOD; LYMPH NODE BIOPSY; PRIORITY JOURNAL; VIRUS REPLICATION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0029930523     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199604010-00007     Document Type: Article

References (43)

1. + mature human T cell populations and clones by human herpesvirus 6. J Immunol 1991;147:685-91.
2. Lusso P, Malnati M, Garzino-Demo A, et al. Infection of natural killer cells by human herpesvirus 6. Nature 1993;362: 458-62.
3. Flammand L, Gosselin J, Stefanescu D, Ablashi D, Menezes J. Immunosuppressive effect of human herpesvirus 6 on T cell functions: suppression of interleukin 2 synthesis and cell proliferation. Blood 1995;85:1263-71.
4. Horvat RT, Parmely MJ, Chandran B. Human herpesvirus 6 inhibits the proliferative responses of human peripheral blood mononuclear cells. J Infect Dis 1993;167:1274-80.
5. Burd EM, Carrigan DR. Human herpesvirus six (HHV-6) associated dysfunction of blood monocytes. Virus Res 1993; 29:79-90.
6. Knox KK, Carrigan DR. In vitro suppression of bone marrow progenitor cell differentiation by human herpesvirus 6 infection. J Infect Dis 1992;165:925-9.
7. Burd EM, Knox KK, Carrigan Dr. Human herpesvirus six mediated suppression of growth factor induced macrophage maturation in human bone marrow cultures. Blood 1993;81: 1645-50.
8. Yoshikawa T, Suga S, Asano Y, et al. Human herpesvirus 6 infection in bone marrow transplantation. Blood 1991;78: 1381-4.
9. Carrigan DR, Drobyski WR, Russler SK, et al. Interstitial pneumonitis associated with human herpesvirus six (HHV-6) infection in marrow transplant patients. Lancet 1991;338: 147-9.
10. Drobyski WR, Dunne WM, Bund EM, et al. Human herpesvirus 6 (HHV-6) infection in allogeneic bone marrow transplant recipients. I. Evidence for a marrow suppressive role for HHV-6 in vivo. J Infect Dis 1993;167:735-9.
11. Carrigan DR, Knox KK. Human herpesvirus six (HHV-6) isolation from bone marrow: HHV-6 associated bone marrow suppression in bone marrow transplant patients. Blood 1994;84:3307-10.
12. Drobyski WR, Knox KK, Majewski D, Carrigan DR. Fatal encephalitis due to variant B human herpesvirus 6 infection in a bone marrow transplant recipient. N Engl J Med 1994; 330:1356-60.
13. Pellet PE, Black JB, Yamamoto M. Human herpesvirus 6: the virus and the search for its role as a human pathogen. Adv Virus Res 1992;41:1-51.
14. Carrigan DR, Knox KK, Tapper MA. Suppression of human immunodeficiency virus type 1 replication by human herpesvirus six. J Infect Dis 1990;162:844-51.
15. + T lymphocytes by HIV-1 and HHV-6. Nature 1989;337:370-3.
16. Gallo RC. HIV - the cause of AIDS; an overview on its biology mechanisms of disease induction, and our attempts to control it. J Acquir Immune Defic Syndr 1988;1:521-5.
17. Knox KK, Carrigan DR. Disseminated active HHV-6 infections in patients with AIDS. Lancet 1994;343:577-8.
18. Pellett PE, Sanchez-Marinez D, Dominguez G, et al. A strongly immunoreactive virion protein of human herpesvirus 6 variant B strain Z29: identification and characterization of the gene and mapping of a variant specific monoclonal antibody reactive epitope. Virology 1993;195:521-31.
19. Knox KK, Pietryga D, Franciosi R, Carrigan DR. Progressive immunodeficiency and fatal pneumonitis associated with HHV-6 infection in an infant. Clin Infect Dis 1995;20: 406-13.
20. Rosenfeld CS, Weinbaum D, Carrigan DR, Knox KK, Andrews DF, Shadduck RK. Late graft failure due to dual bone marrow infection with variants A and B of human herpesvirus 6. Exp Hematol 1995;23:626-9.
21. Chandran B, Tirawatnapong S, Pfeiffer B, Ablashi DV. Antigenic relationships among human herpesvirus 6 isolates. J Med Virol 1992;247-54.
22. Balachandran N. Proteins of human herpesvirus 6. In: Ablashi DV, Krueger GRF, Salahuddin SZ, eds. Human herpesvirus 6: epidemiology, molecular biology and clinical pathology. Amsterdam: Elsevier Science, 1992:97-120.
23. Wyatt LS, Balachandran N, Frenkel N. Variations in the replication and antigenic properties of human herpesvirus 6 strains. J Infect Dis 1990;162:852-7.
24. Ablashi DV, Balachandran N, Josephs SF, et al. Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Virology 1991;184: 545-52.
25. Russler SK, Tapper MA, Knox KK, Liepins A, Carrigan DR. Pneumonitis associated with coinfection by human herpesvirus six and legionella in an immunocompetent adult. Am J Pathol 1991;138:1405-11.
26. Gompels UA, Luxton J, Knox KK, Carrigan Dr. Chronic bone marrow suppression in an immunocompetent adult with persistent marrow infection by human herpesvirus 6. Lancet 1994;343:735-6.
27. Downing RG, Sewankambo N, Serwadda D, et al. Isolation of human lymphotropic herpesviruses from Uganda. Lancet 1987;2:390.
28. Martin MED, Nicholas J, Thomson BJ, Newman C, Honess RW. Identification of a transactivating function mapping to the putative immediate early locus of human herpesvirus 6. J Virol 1991;65:5381-90.
29. Embretson J, Zupancic M, Ribas JL, et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993;362:359-62.
30. Pantaleo G, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-8.
31. Balachandran N, Ameise RE, Zhou WW, Chang CK. Identification of proteins specific for human herpesvirus 6 infected human T cells. J Virol 1989;63:2835-40.
32. Agut H, Guetard D, Collandre H, et al. Concomitant infection by human herpesvirus 6, HTLV-1 and HIV-2. Lancet 1988;1:712.
33. Agut H, Kerouedan D, M'Pele P, et al. Cocultivation of human herpesvirus 6 and HIV-1 from blood lymphocytes. Res Virol 1989;140:23-6.
34. Salahuddin SZ, Ablashi DV, Markham PD, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986;234:596-601.
35. Secchiero P, Carrigan DR, Benedetti L, et al. Detection of HHV-6 in serum of immunosuppressed individuals by polymerase chain reaction. J Infect Dis 1995;171:273-80.
36. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-22.
37. Ho DD, Neumann U, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373:123-6.
38. Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995;261:483-9.
39. Folks TM, Justement J, Kinter A, et al. Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. J Immunol 1988; 140:1117-22.
40. Flammand L, Gosselin J, D'Addario M, et al. Human herpesvirus 6 induces interleukin-1B and tumor necrosis factor alpha, but not interleukin-6 in peripheral blood mononuclear cell cultures. J Virol 1991;65:5105-10.
41. Corbellino M, Lusso P, Gallo RC, et al. Disseminated human herpesvirus 6 infection in AIDS. Lancet 1993;342:1242.
42. Fauci AS. Cytokine regulation of HIV expression. Lymphokine Cytokine Res 1990;9:527-31.
43. Ensoli B, Lusso P, Schlachter F, et al. Human herpesvirus 6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer. EMBO J 1989;8: 3019-27.